Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Bullous pemphigoid can look like erythema multiforme, so awareness is needed for proper treatment.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Alopecia areata patients are more likely to have thyroid disorders than healthy individuals.

Children with autoimmune gastritis showed improved intestinal health over time and should be checked for other autoimmune conditions.

Alopecia areata and polymyalgia rheumatica may be linked autoimmune conditions.

Anti-SRP myopathy can be linked to systemic lupus erythematosus and may improve with specific treatment.

Antibody treatments show promise for hair loss but need more research.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

Type 1 diabetes may cause certain autoimmune diseases in Europeans.

A woman with undifferentiated connective tissue disease was diagnosed with renal amyloidosis and carpal tunnel syndrome.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

DNA virus-induced tumors have consistent isozyme profiles, unlike other tumor types.

Serum calprotectin is not a reliable marker for alopecia areata activity.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Fetal skin has unique immune cells different from adult skin.

PRAME helps distinguish between benign and malignant skin cells in most cases.